SLC22A4 and RUNX1: Identification of RA susceptible genes

Journal of Molecular Medicine

Volumn 82, Issue 9, 2004, Pages 558-564

  Yamada, Ryo ^a   Tokuhiro, Shinya ^a   Chang, Xiotian ^a   Yamamoto, Kazuhiko ^a,b  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Rheumatoid arthritis; RUNX1; SLC22A4

Indexed keywords

ORGANIC CATION TRANSPORTER;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; RUNX1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC22A4 GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 5; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE TRANSPORT PROTEINS; MICE; MODELS, GENETIC; MULTIFACTORIAL INHERITANCE; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PSORIASIS; TRANSCRIPTION FACTORS;

EID: 4744342646     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-004-0547-y     Document Type: Review

References (50)

1. Seldin MF, Amos CI, Ward R, Gregersen PK (1999) The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 42:1071-1079
2. Goldbach-Mansky R et al. (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236-243
3. Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273:1516-1517
4. Tokuhiro S et al. (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35:341-348
5. Aho K, Koskenvuo M, Tuominen J, Kaprio J (1986) Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 13:899-902
6. Silman AJ et al. (1993) Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32:903-907
7. Jarvinen P, Aho K (1994) Twin studies in rheumatic diseases. Semin Arthritis Rheum 24:19-28
8. Wolfe F, Kleinheksel SM, Khan MA (1988) Familial vs sporadic rheumatoid arthritis: a comparison of the demographic and clinical characteristics of 956 patients. J Rheumatol 15:400-404
9. Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36:178-182
10. Hasstedt SJ, Clegg DO, Ingles L, Ward RH (1994) HLA-linked rheumatoid arthritis. Am J Hum Genet 55:738-746
11. Nepom GT (1998) Major histocompatibility complex-directed susceptibility to rheumatoid arthritis. Adv Immunol 68:315-332
12. Reveille JD (1998) The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 10:187-200
13. Cornelis F et al. (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 95:10746-10750
14. Shiozawa S et al. (1998) Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 10:1891-1895
15. Jawaheer D et al. (2001) A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 68:927-936
16. MacKay K et al. (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 46:632-639
17. Ohnishi Y et al. (2001) A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 46:471-477
18. Ozaki K et al. (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650-654
19. Suzuki A et al. (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395-402
20. Yamada R, Suzuki A, Chang X, Yamamoto K (2003) Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene. Trends Mol Med 9:503-508
21. Grunig G et al. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-2263
22. Rioux JD et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 29:223-228
23. Mansur AH, Bishop DT, Markham AF, Britton J, Morrison JF (1998) Association study of asthma and atopy traits and chromosome 5q cytokine cluster markers. Clin Exp Allergy 28:141-150
24. Kauppi P. et al. (2001) A second-generation association study of the 5q31 cytokine gene cluster and the interleukin-4 receptor in asthma. Genomics 77:35-42
25. Lee JK, Park C, Kimm K, Rutherford MS (2002) Genome-wide multilocus analysis for immune-mediated complex diseases. Biochem Biophys Res Commun 295:771-773
26. Giallourakis C et al. (2003) IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 73:205-211
27. Nezu K et al. (1999) Thoracoscopic lung volume reduction surgery for emphysema. Evaluation using ventilation-perfusion scintigraphy. Jpn J Thorac Cardiovasc Surg 47:267-272
28. Tamai I et al. (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064-40072
29. Tamai I et al. (2001) Na (+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta 1512:273-284
30. Nezu J et al. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94
31. Tamai I et al. (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111
32. Yabuuchi H et al. (1999) Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289:768-773
33. Motohashi H et al. (2002) Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 13:866-874
34. Wu X, et al. (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776-32786
35. Roumier C et al. (2003) New mechanisms of AML1 gene alteration in hematological malignancies. Leukemia 17:9-16
36. Downing JR (2001) AML1/CBFbeta transcription complex: its role in normal hematopoiesis and leukemia. Leukemia 15:664-665
37. Coffman JA (2003) Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol Int 27:315-324
38. Nucifora G, Rowley JD (1995) AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1-14
39. Romana SP et al. (1995) High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263-4269
40. Osato M et al. (1999) Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 93:1817-1824
41. Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S (2000) AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia. Haematologica 85:362-366
42. Song WJ. et al. (1999) Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23:166-175
43. Prokunina L et al. (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32:666-669
44. Helms C et al. (2003) A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 35:349-356
45. Surinya KH, Cox TC, May BK (1998) Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem 273:16798-16809
46. Ghayor C et al. (2000) Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration. J Biol Chem 275:27421-27438
47. Beohar N, Kawamoto S (1998) Transcriptional regulation of the human nonmuscle myosin II heavy chain-A gene. Identification of three clustered cis-elements in intron-1 which modulate transcription in a cell type- and differentiation state-dependent manner. J Biol Chem 273:9168-9178
48. Lutterbach B, Hiebert SW (2000) Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 245:223-235
49. Olofsson P et al. (2003) Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33:25-32
50. Peltekova VD, Wintle RF, Rubin LA et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36:471-475